Their son had an atrial septal defect, a ventricular septal defect, tricuspid atresia and a hypoplastic right ventricle. In ...

Payment will be provided when TTVR is delivered for an FDA-approved indication in the context of a CMS-approved study.

CMS has approved Medicare and Medicaid coverage for transcatheter tricuspid valve replacement procedures for the treatment of ...

The final U.S. Medicare national coverage determination for transcatheter tricuspid valve replacement (TTVR) devices comes ...

US medical device company Laplace Interventional has completed a Series C financing round to support the completion of an early feasibility study (EFS) of its transcatheter tricuspid valve (TTV) ...

Partial heart transplants provide a range of lifesaving options for children with complex congenital heart conditions, and can lead to a domino effect of life-saving procedures.

The company develops a prosthetic valve device designed to improve the quality of life for those with tricuspid regurgitation (TR). Delivered through a minimally invasive procedure, the valve ...

From wetting the bed to acne, we have crunched the numbers on the success rate of every single disability claim. It comes ...

Laplace Interventional’s device aims to offer an improvement to the quality of life to patients worldwide diagnosed with Tricuspid Regurgitation (TR). Laplace Interventional is developing a prosthetic ...

Fontan circulation (FC) in complex congenital heart disease is characterized by altered hemodynamics and associated with Fontan‐associated liver disease. Patients with FC may exhibit abnormalities in ...